Neurotrophic factors in the treatment of neurologic diseases;Neurotrophe faktoren in der therapie neurologischer erkrankungen

Aktuelle Neurologie

Volumn 24, Issue 4, 1997, Pages 170-174

  Ochs, G ^a   Schrank, B ^a   Toyka, K ^a   Sendtner, M ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CILIARY NEUROTROPHIC FACTOR; NERVE GROWTH FACTOR; NEUROTROPHIC FACTOR; NEUROTROPHIN 3; SOMATOMEDIN C;

AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CLINICAL TRIAL; DEGENERATIVE DISEASE; DIABETIC NEUROPATHY; DRUG EFFICACY; DRUG TOLERABILITY; HUMAN; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRATHECAL DRUG ADMINISTRATION; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PHASE 3 CLINICAL TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT OUTCOME;

EID: 0030931528     PISSN: 03024350     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1017804     Document Type: Article

References (42)

1. Aebischer, P., M. Schluep, N. Deglon, et al.: Intrathecal delivery of CNTF using encapsulated genetically modified xenogeneic cells in amyotrophic lateral sclerosis patients. Nature Med. 2 (1996) 696-699
2. ALS CNTF Treatment Study (ACTS): Recombinant human ciliary neurotrophic factor (rhCNTF) in amyotrophic lateral sclerosis (ALS) patients: Phase I-II safety, tolerability and pharmacokinetic studies (abstract). Neurology 43 (1993) A416
3. ALS CNTF Treatment Study (ACTS): A phase 1 study of recombinant human ciliary neurotrophic factor (rHCNTF) in patients with amyotrophic lateral sclerosis. Clin. Neuropharmacol. 18 (1995) 515-532
4. ALS CNTF Treatment Study (ACTS): A double-blind placebo-controlled clinical trial of subcutaneous recombinant human ciliary neurotrophic factor (rHCNTF) in amyotrophic lateral sclerosis. Neurology 46 (1996) 1244-1249
5. Apfel, S. C., J. A. Kessler.: Neurotrophic factors in the therapy of peripheral neuropathy. Bailliere's Clin. Neurol. 4 (1995) 593-606
6. Arakawa, Y., M. Sendtner, H. Thoenen: Survival effect of ciliary neurotrophic factor (CNTF) on chick embryonic motoneurons in culture: comparison with other neurotrophic factors and cytokines. J. Neurosci. 10 (1990) 3507-3515
7. Bradley, W. G.: The BDNF Trial Group: A phase I/II study of recombinant human brain-derived neurotrophic factor in patients with amyotrophic lateral sclerosis. Ann. Neurol. 38 (1995) 971
8. Caroni, P., P. Grandes: Nerve sprouting in innervated adult skeletal muscle induced by exposure to elevated levels of insulin-like growth factors. J. Cell Biol. 110 (1990) 1307-1317
9. Carter, B. D., C. Kaltschmidt, B. Kaltschmidt et al.: Selective activation of NF- kappa B by nerve growth factor through the neurotrophin receptor p75. Science 272 (1996) 542-545
10. Dittrich, F., G. Ochs, A. Grosse-Wilde et al.: Pharmacokinctics of intrathecally applied BDNF and effects on spinal motoneurons. Exp. Neurol. 141 (1996) 225-239
11. Dittrich, F., H. Thoenen, M. Sendtner: Ciliary neurotrophic factor: Pharmacokinetics and acute-phase response in rat. Ann. Neurol. 35 (1994) 151-163
12. Ernfors, P., K. Lee, J. Kucera et al.: Lack of neurotrophin-3 leads to deficiencies in the peripheral nervous system and loss of limb proprioceptive afferents. Cell 77 (1994) 503-512.
13. Galpern, W. R., D. M. Frim, S. B. Tatter et al.: Cell-mediated delivery of brain-derived neurotrophic factor enhances dopamine levels in an MPP+ rat model of substantia nigra degeneration. Cell Transplant 5 (1996) 225-232
14. Gurney, M. E., H. Yamamoto, Y. Kwon: Induction of motor neuron sprouting in vivo by ciliary neurotrophic factor and basic fibroblast growth factor. J. Neurosci. 12 (1992) 3241-3247
15. Henderson, J. T., N. A. Seniuk, P. M. Richardson et al.: Systemic administration of ciliary neurotrophic factor induces cachexia in rodents. J. Clin. Invest. 93 (1994) 2632-2638
16. Hughes, R. A., M. Sendtner, H. Thoenen: Members of several gene families influence survival of rat motoneurons in vitro and in vivo. J. Neurosci. Res. 36 (1993) 663-671
17. Ikeda, K., B. Klinkosz, T. Greene et al: Effects of brain-derived neurotrophic factor on motor dysfunction Wobbler mouse motor neuron disease. Ann. Neurol. 37 (1995) 505-511
18. Iwamoto, Y., K. Yang, G. L. Clifton et al.: Liposome-mediated BDNF cDNA transfer in intact and injured rat brain. Neuroreport 7 (1996) 609-612
19. Kanje, M., A. Skottner, J. Sjoberg et al.: Insulin-like growth factor I (IGF-I) stimulates regeneration of the rat sciatic nerve. Brain Res. 486 (1989) 396-398
20. Lai, E. C., K. Felice, B. W. Festoff et al.: A double-blind, placebo-controlled study of recombinant human insulin-like growth factor in the treatment of amyotrophic lateral sclerosis. Ann. Neurol. 38 (1995) 971
21. Lange, D. J., K. J. Felice, M. J. Grewal et al.: A double-blind, placebo-controlled therapeutic trial to assess the efficacy of recombinant human insulin-like growth hormone (abstract). 6th International Symposium on ALS/MND, Dublin 30.10.-1.11.1995
22. LaVail, M. M., K. Unoki, D. Yasumura et al.: Multiple growth factors, cytokines, and neurotrophins rescue photoreceptors from the damaging effects of constant light. Proc. Natl. Acad. Sci. USA 89 (1992) 11249-11253
23. Li, L., R. W. Oppenheim, M. Lei et al.: Neurotrophic agents prevent motoneuron death following sciatic nerve section in the neonatal mouse. J. Neurobiol. 25 (1994) 759-766
24. Miller, R. G., W. W. Bryan, M. Dietz et al.: Safety, tolerability and pharmacokinetics of recombinant human ciliary neurotrophic factor (rhCNTF) in patients with amyotrophic lateral sclerosis (abstract). Ann. Neurol. 34 (1993) 304
25. Miller, R. G., J. H. Petajan, W. W. Bryan et al.: A placebo-controlled trial of recombinant human ciliary neurotrophic (rhCNTF) factor in amyotrophic lateral sclerosis. Ann. Neurol. 39 (1996) 256-260
26. Mitsumoto, H., K. Ikeda, B. Klinkosz et al.: Arrest of motor neuron disease in wobbler mice cotreated with CNTF and BDNF. Science 265 (1994) 1107-1110
27. Mufson, E. J., J. S. Kroin, Y. T. Liu et al.: Intrastriatal and intraventricular infusion of brain-derived neurotrophic factor in the cynomologous monkey: Distribution, retrograde transport and colocalization with substantia nigra dopamine-containing neurons. Neuroscience 71 (1996) 179-191
28. Nakahara, Y., F. H. Gage, M. H. Tuszynski: Grafts of fibroblasts genetically modified to secrete NGF, BDNF, NT-3, or basic FGF elicit differential responses in the adult spinal cord. Cell Transplant 5 (1996) 191-204
29. Oppenheim, R. W., Y. Qin Wei, D. Prevette et al.: Brain-derived neurotrophic factor rescues developing avian motoneurons from cell death. Nature 360 (1992) 755-757
30. Rask, C., S. C. Apfel, B. T. Adornato et al.: An overview of the clinical experience with systematic administration of nerve growth factor in treating peripheral nervous system disorders. Ann. Neurol. 38 (1995) 317
31. Saggio, I., I. Gloaguen, G. Poiana et al.: CNTF variants with increased biological potency and receptor selectivity define a functional site of receptor interaction. Embo J. 14 (1995) 3045-3054
32. Sagot, Y., S. A. Tan, E. Baetge et al.: Polymer encapsulated cell lines genetically engineered to release ciliary neurotrophic factor can slow down progressive motor neuronopathy in the mouse. Eur. J. Neurosci. 7 (1995) 1313-1322
33. Sahenk, Z., J. Seharaseyon, J. R. Mendell: CNTF potentiates peripheral nerve regeneration. Brain Res. 655 (1994) 246-250
34. Sendtner, M.: Molecular biology of neurotrophic factors. Bailliere's Clin. Neurol. 4 (1995) 575-591
35. Sendtner, M., B. Holtmann, R. Kolbeck et al.: Brain-derived neurotrophic factor prevents the death of motoneurons in newborn rats after nerve section. Nature 360 (1992) 757-759
36. Sendtner, M., G. W. Kreutzberg, H. Thoenen: Ciliary neurotrophic factor prevents the degeneration of motor neurons after axotomy. Nature 345 (1990) 440-441
37. Sendtner, M., H. Schmalbruch, K. A. Stöckli et al.: Ciliary neurotrophic factor prevents degeneration of motor neurons in mouse mutant progressive motor neuronopathy. Nature 358 (1992) 502 -504
38. Sendtner, M., K. A. Stöckli, H. Thoenen: Synthesis and localization of ciliary neurotrophic factor in the sciatic nerve of the adult rat after lesion and during regeneration. J. Cell Biol. 118 (1992) 139-148
39. Staecker, H., W. Liu, C. Hartnick et al.: NT-3 combined with CNTF promotes survival of neurons in modiolus-spiral ganglion explants. Neuroreport 6 (1995) 1533-1537
40. Thoenen, H., R. A. Hughes, M. Sendtner: Trophic support of motoneurons: Physiological, pathophysiological, and therapeutic implications. Exp. Neurol. 124 (1993) 47-55
41. Tomac, A., J. Widenfalk, L. Lin et al.: Retrograde axonal transport of glial cell line-derived neurotrophic factor in the adult nigrostriatal system suggests a trophic role in the adult. Proc. Natl. Acad. Sci. USA 92 (1995) 8274-8278
42. Yan, Q., C. Matheson, J. Sun et al.: Distribution of intracerebral ventricularly administered neurotrophins in rat brain and its correlation with trk receptor expression. Exp. Neurol. 127 (1994) 23-36